| | | | |
| Please limit public testimony to 3 minutes. The public is also welcome to |
|
| submit copies of written testimony to the Committee. |
|
|
| | | | |
| | Relating to disease control programs to reduce the risk of certain communicable diseases. |
|
|
|
|
| | | | |
| | Relating to advance directives or health care or treatment decisions made by or on behalf of patients. |
|
|
|
|
| | | | |
| | Relating to the regulation of certain long-term care facilities, including the establishment of late fees and changes to administrative penalties, and relating to the office of long-term care ombudsman. |
|
|
|
|
| | | | |
| | Relating to designating the Donor Education, Awareness, and Registry Program of Texas as the Glenda Dawson Donate Life-Texas Registry. |
|
|
|
|
| | | | |
| | Relating to the enrollment of certain children and recipients of medical assistance in group health benefit plans. |
|
|
|
|
| | | | |
| | Relating to expansion of the use of consumer direction for delivery of certain services to persons with disabilities and elderly persons. |
|
|
|
|
| | | | |
| | Relating to the creation of the lifespan respite services pilot program. |
|
|
|
|
| | | | |
| | Relating to a public awareness campaign concerning certain solicitations for the purchase of prescription drugs. |
|
|
|
|
| | | | |
| | Relating to the implementation of the community living options information process for certain persons with mental retardation at certain institutions. |
|
|
|
|